Figure 5
From: Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
(a) Model showing the docking of compound 20p into the FXR ligand binding domain obtained from the X-ray crystal structure PDB 1OSH. (b) GW4064 (4) is shown for comparison (3DCT).
